Adam Mendelsohn, PhD, CEO of Vivani Medical

Vivani Medical, Inc.

Adam Mendelsohn, PhD, CEO of Vivani Medical, holds the miniature semaglutide (GLP-1) implant designed for once- or twice-yearly administration.

Format

JPEG

Source

Vivani Medical, Inc.

Téléchargements